currently the only sirolimus-coated balloon globally approved with CE certification. It is the most clinically studied sirolimus-coated balloon for peripheral... 14 KB (1,375 words) - 21:32, 12 March 2024 |
Lymphangioma (section Sirolimus) systemic medication, or through observation. Sirolimus is used to treat lymphangioma. Treatment with sirolimus can decrease pain and the fullness of venous... 21 KB (2,399 words) - 07:31, 9 April 2024 |
Immunosuppressive drug (section Sirolimus) Everolimus is an analog of sirolimus and also is an mTOR inhibitor. Zotarolimus is a semi-synthetic derivative of sirolimus used in drug-eluting stents... 29 KB (3,309 words) - 04:27, 30 January 2024 |
needed] It is the 40-O-(2-hydroxyethyl) derivative of sirolimus and works similarly to sirolimus as an inhibitor of mammalian target of rapamycin (mTOR)... 27 KB (2,534 words) - 23:12, 30 March 2024 |
MTOR inhibitors (section Sirolimus) sites for mTOR and FKBP12. The bacterial natural product rapamycin or sirolimus, a cytostatic agent, has been used in combination therapy with corticosteroids... 57 KB (6,276 words) - 20:45, 9 May 2024 |
provide a "scaffold" to open the artery. An anti-rejection-type medication, sirolimus, helps to limit the overgrowth of normal cells while the artery heals... 2 KB (178 words) - 20:25, 12 March 2024 |